Preliminary Study on a Potential Panel for Quality Assurance of ELISPOT

The ELISPOT assay is increasingly used for assessing cellular immune responses in clinical trials of HIV-1 or cancer vaccines. However, to date, data from clinical trials do not consistently show that immune responses are correlated with clinical endpoints. This is due in part to the lack of assay s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Virologica Sinica 2008, Vol.23 (5), p.330-338
Hauptverfasser:	Zhang, Chun-tao, Wu, Yu, Zhao, Chen-yan, Hong, Kun-xue, Liu, Chun-yu, Wang, Ying, Zhong, Ping, Nie, Jian-hui, Wu, Xue-lin, Wang, You-chun
Format:	Artikel
Sprache:	eng
Schlagworte:	Biochemistry Biomedical and Life Sciences Biomedicine Cancer vaccines Clinical trials Cryopreservation Enzyme-linked immunosorbent assay HIV Human immunodeficiency virus Immune response Immune response (cell-mediated) Laboratories Leukocytes (mononuclear) Medical Microbiology Microbial Genetics and Genomics Microbiology Oncology Peptides Peripheral blood mononuclear cells Quality assurance Quality control Standardization Virology γ-Interferon 免疫系统斑点法测试方法
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!